Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09EAE
|
|||
| Former ID |
DNC007765
|
|||
| Drug Name |
SU-6689
|
|||
| Synonyms |
SU-6689; CHEMBL426078; Indolinone based inhibitor, 2f; SCHEMBL5203211; BDBM17028
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H14N2O2
|
|||
| Canonical SMILES |
CC1=CC(=C(N1)C=C2C3=C(C=CC(=C3)O)NC2=O)C
|
|||
| InChI |
1S/C15H14N2O2/c1-8-5-9(2)16-14(8)7-12-11-6-10(18)3-4-13(11)17-15(12)19/h3-7,16,18H,1-2H3,(H,17,19)/b12-7-
|
|||
| InChIKey |
GUXYHZUGDWFOBA-GHXNOFRVSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3814-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.